Biobased and Renewable Products News: Capitol Hill

November 9, 2018
Call For Candidate Chemicals For Equivalency Determinations
Is your company engaged in Class 2 chemistries that are similar to existing Class 2 chemicals but are derived from an innovative bio-source? We are looking for pioneering companies working on new biobased Class 2 chemicals to assist in advancing an important project with the U.S. Environmental Protection Agency (EPA).   ISSUE:  While EPA sustainability goals would seemingly include adoption of improved biobased technologies, EPA’s policies under the Toxic Substances Control Act (TSCA) mean that many novel, sustainable technologies are considered “new chemicals” ... read more >
February 15, 2019
U.S. Representative Ocasio-Cortez Releases Green New Deal
On February 7, 2019, Representative Ocasio-Cortez (D-NY), in partnership with Senator Ed Markey (D- MA), released the outline for the Green New Deal, a policy package designed to reduce greenhouse gas (GHG) emissions through the transformation of the U.S. economy. The outline includes highlights on the systemic impact from climate change, particularly on women, indigenous populations, deindustrialized and migrant communities, the poor, communities of color, depopulated rural communities, low-income workers, the elderly, the unhoused, people with disabilities, and youth. Stating that climate ... read more >
January 18, 2019
Environmental Groups Urge U.S. Representatives To Continue Push For A Green New Deal
On January 10, 2019, more than 600 environmental groups signed a letter submitted to U.S. Representatives urging them to consider certain principles on climate change as a Green New Deal is developed.  As the 116th Congress begins to take into account climate change legislation, environmental groups would like to see affirmative actions focused on six key areas: Fossil fuel phase-out; Transition into renewable energy; The role of public transportation; The power of the Clean Air Act (CAA); Community-led transitions; and, The importance of indigenous rights. Tying together these ... read more >
January 11, 2019
B&C Releases 2019 Forecast On U.S. Federal And International Chemical Regulatory Policy
On January 8, 2019, B&C and its consulting affiliate The Acta Group (Acta®) published the 2019 Forecast.  The document details the legal, scientific, and regulatory trends in U.S. and global chemical law, providing informed judgment as to the shape of key developments we are likely to see in 2019.  Sections on biobased products and biotechnology are included in the document.  The full document can be accessed ... read more >
December 21, 2018
Democratic Leader Requests Clean Energy Infrastructure Package In 2019
On December 6, 2018, U.S. Senator Charles E. Schumer (D-NY) wrote a letter to President Donald Trump requesting that, in 2019, any infrastructure package to be considered include a focus on the clean energy economy to address climate change. Emphasizing that climate change is, in fact, real and caused by humans, Senator Schumer refers to the Administration’s recent National Climate Assessment report and the drastic need to reduce emissions. In the letter, Senator Schumer outlines a number of policies that must be included in an infrastructure package in the next Congress. Among these ... read more >
November 9, 2018
FDA Submits A Collection Of Information Proposal To OMB
On November 5, 2018, the U.S. Food and Drug Administration (FDA) announced that a proposed collection of information on the Biosimilars User Fee Program was submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. FDA’s Biosimilars User Fee Program was established under the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), which amended the Public Health Service Act through the addition of Section 351(k). The BPCI Act also amended the Federal Food, Drug, and Cosmetic Act to include Section 351(k) under ... read more >
November 2, 2018
FDA Releases Statement On A New Plant And Animal Biotechnology Innovation Action Plan
On October 30, 2018, the U.S. Food and Drug Administration (FDA) published a statement by FDA Commissioner Scott Gottlieb, M.D., and FDA Deputy Commissioner Anna Abram regarding FDA’s new action plan to advance plant and animal biotechnology innovation.  Aimed at ensuring the safety of plant and animal biotechnology products and avoiding unnecessary barriers to future innovation, the Action Plan focuses on three key priorities: Advancing public health by promoting innovation; Strengthening public outreach and communication; and Increasing engagement with domestic and ... read more >
October 26, 2018
Trump Administration Releases Its Fall 2018 Agenda
On October 16, 2018, the Office of Information and Regulatory Affairs released the Trump Administration’s Fall 2018 Unified Agenda of Regulatory and Deregulatory Actions (Agenda). The Agenda aims to report on actions that administrative agencies, such as EPA, plan to put forward in the near- and long-terms. As its name implies, the Agenda includes both regulatory and deregulatory actions and attempts to justify any burden associated with these actions. According to its announcement, it should reflect four broad regulatory reform priorities: advancing regulatory reform, public notice of ... read more >
October 19, 2018
Presidential Determination:  Alane Fuel Cells
On October 11, 2018, President Trump issued a Presidential Determination that the development and purchase of equipment and materials needed for alane fuel cells are essential to the national defense.  Alane fuel cells are, essentially, comprised of aluminum hydride and are possible alternatives to hydrogen fuel cells.  According to manufacturers, the only byproducts are water and aluminum, the latter of which can be recycled.   Issuing the determination under Section 303 of the Defense Production Act of 1950, the President stated that “United States industry cannot ... read more >
October 19, 2018
Democrats Express Concern Over RFS Waivers
On October 15, 2018, U.S. Representatives Ruben Gallego (D-AZ) and Danny Davis (D-IL) submitted a letter to the U.S. Environmental Protection Agency (EPA) expressing concern over President Trump’s issuance of waivers to the Renewable Fuel Standard (RFS). Particularly worried about EPA’s recent actions to waive RFS blending requirements, the letter, signed by 19 members of Congress, urges EPA “to halt the issuance of additional RFS waivers and to reallocate waived gallons in the 2019 Renewable Volume Obligations.” According to the letter, the issuance of these waivers ... read more >
 1 2 3 >  Last › View 10 | 25 | 50 | 100 per page
 
BIOBASED AND RENEWABLE PRODUCTS ADVOCACY GROUP
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
(202) 833-6580 | www.braginfo.org
Contact
 
Privacy Policy | Acceptable Use Policy 
©2019 Biobased And Renewable Products Advocacy Group
All Rights Reserved.